A jury in Chicago has rejected an Illinois woman's claim that the now-discontinued heartburn drug Zantac caused her colon cancer. The trial, which involved GlaxoSmithKline and Boehringer Ingelheim, was the first of thousands of lawsuits making similar allegations. The plaintiff, an 89-year-old woman from Brookfield, alleged that Zantac caused her colon cancer and sought $640 million in damages. The jury, composed of nine women and three men, deliberated over the case. Lawyers for the pharmaceutical companies argued that no credible evidence linked Zantac to cancer, and the jury ultimately sided with the defense. The woman also claimed debilitating symptoms as part of her case.
A jury in Chicago rejected an Illinois woman’s claim that the now-discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations https://t.co/R5QpeHFBzF https://t.co/r3ubhrlAwN
Zantac didn’t cause 89-year-old woman's cancer, jury says in first trial over drug https://t.co/Vwr3SwnuD9 https://t.co/zruq57jXmi
A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations. https://t.co/IiigdPaWxm https://t.co/IiigdPaWxm
Zantac didn’t cause 89-year-old woman’s cancer, jury says in first trial over drug https://t.co/ySAYpa5X6N https://t.co/QEaQDHqTNi
A jury in Chicago rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations https://t.co/rPZ5MyRZVz https://t.co/GKAU1KzUbs
BREAKING: A Chicago jury found that Zantac heartburn medication and its generic counterparts sold by GlaxoSmithKline and Boehringer Ingelheim are not responsible for an Illinois woman's colon cancer and her subsequent, debilitating symptoms. https://t.co/7FYpgQKccy https://t.co/k9Bhgr2OzB
ZANTAC NOT A CAUSE OF WOMAN’S CANCER, JURY SAYS IN FIRST TRIAL OVER DRUG $GSK
Attorneys for GlaxoSmithKline and Boehringer Ingelheim told a jury that no one besides a plaintiff's paid witnesses have said publicly that Zantac causes colon cancer, calling on the jurors to reject claims that the companies owe $640 million. https://t.co/g5hmGkWatL https://t.co/YVezSYfjj8
It's now up to a jury of nine women and three men to deliberate over whether the heartburn drug Zantac caused an 89-year-old Brookfield woman’s colon cancer. https://t.co/b6B6iO2FBf
'Cancer causer or heartburn healer? Lawyers make closing pitches in first jury trial over Zantac cancer claims.' @kwashy12 reports. https://t.co/BNa8rIHiiJ